摘要:
A metered dose inhaler for use with a pressurized aerosol container (25) which is preferably breath-actuated. A preload (460) is applied to the internal aerosol valve by an amount sufficient to result in a dose release, but this is prevented by the application of a pneumatic resisting force. The inhaler comprises a release device (520) which, upon actuation, releases the resisting force and allows the preload to actuate the aerosol valve. A metered dose of medicament is then released for inhalation by the patient. The pneumatic resisting force is established by a negative pressure region (600) defined in part by a diaphragm (440). The diaphragm (440) includes a central disk (441) of a first, relatively high stiffness material "A" and a peripheral ring, coupled by a flexure of a second, relatively low stiffness material "B".
摘要:
A medicament delivery system (10) comprises a nebulizer device (11), an open-faced mist chamber-defining element (12) having a tubular input/output port (31), a tubular inhalation port (15) connecting to the output port (31) of the mist chamber-defining element (12), and a sealed unit dose ampoule (14) adapted to fit within the mist chamber-defining element (12). The nebulizer device (11) includes an ultrasonic transducer (21) responsive to applied electrical energy to generate ultrasonic energy, an ultrasonic transmission horn (23) between an input energy surface (25) at an input end and an energy delivery surface (27) at an output end. The sealed unit dose ampoule (14) can be placed directly into the nebulizer device (11) and acts as both the dose cup and baffle, so that the chance of spillage of drug and the number of components to be cleaned are minimized. The unit dose ampoule (14) has a conical base (28) to allow ultrasonic energy conducted from the ultrasonic system to be concentrated at the base of the ampoule (14). The inhalation port (15) includes an inhalation valve (62) and an exhalation valve (64).
摘要:
The present invention relates to a new microbial process for the preparation of the compound of formula (I) from a compound of general formula (II) wherein R+ stands for an alkali metal or ammonium ion, by the submerged cultivation of the strain able to 6β-hydroxylate a compound of formula (II) in aerobic fermentation and by the separation and purification of the product of formula (I) formed in the course of the bioconversion, which comprises cultivating a strain of the genera Micromonospora able to 6β-hydroxylate a compound of the general formula (II), wherein R+ is as defined above, on a nutrient medium containing assimilable carbon and nitrogen sources and mineral salts at 25-32 °C, thereafter feeding the substrate to be transformed into the developed culture, then fermenting the substrate until the end of bioconversion, then separating the compound of formula (I) from the culture broth and, if desired, purifying the same.